Reported Q: Q1 2025 Rev YoY: -5.3% EPS YoY: -931.4% Move: +1.98%
Neogen Corporation
NEOG
$10.80 1.98%
Exchange NASDAQ Sector Healthcare Industry Medical Diagnostics Research
Q1 2025
Published: Oct 10, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for NEOG

Reported

Report Date

Oct 10, 2024

Quarter Q1 2025

Revenue

216.96M

YoY: -5.3%

EPS

-0.06

YoY: -931.4%

Market Move

+1.98%

Previous quarter: N/A

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $216.96M down 5.3% year-over-year
  • EPS of $-0.06 decreased by 931.4% from previous year
  • Gross margin of 48.4%
  • Net income of -12.61M
  • "Regaining market share is the top priority." - John Adent
NEOG
Company NEOG

Executive Summary

Neogen Corporation (NEOG) reported QQ1 2025 revenues of $216.964 million, a YoY decline of 5.25% and QoQ decline of 8.37%, reflecting the seasonally weak first quarter and ongoing transition costs post-3M Food Safety integration. Core revenue fell 1% YoY with a notable FX headwind of 390 basis points, while gross margin compressed to 48.4% (down 260 bps YoY), contributing to a first-quarter operating margin near break-even (operating income of $2.6 million, 1.0% of revenue) and a negative net income of $12.6 million (-5.81% of revenue). Adjusted EBITDA stood at $44.0 million, yielding a 20.1% margin, down ~280 bps YoY as lower volumes and higher shipping/distribution costs weighed on profitability. Management maintained 2025 guidance, signaling that Q1 will be the trough for margins and that improvements will emerge in the second half through higher volumes, gross margin expansion, and ongoing cost discipline, including distribution optimization. The company exited ERP-related shipping constraints and completed the relocation of the former 3M sample collection line, with normalization of production expected by Q3. Management remains focused on regaining market share, expanding Petrifilm as a platform (including the announced high-volume reader feeder), and accelerating international growth, particularly in Latin America, Europe, and Asia-Pacific. Net debt remained elevated at $771.3 million (gross debt $900.0 million) with cash of $120.0 million, and the company still targets roughly 3x net leverage by year-end. Overall, NEOG is balancing a clearer path to revenue growth with ongoing margin normalization and capital-allocation discipline as it integrates a transformative acquisition and expands in international markets.

Key Performance Indicators

Revenue
Decreasing
216.96M
QoQ: -8.37% | YoY: -5.25%
Gross Profit
Decreasing
104.93M
48.36% margin
QoQ: -7.54% | YoY: -10.14%
Operating Income
Decreasing
2.26M
QoQ: -87.16% | YoY: -88.20%
Net Income
Decreasing
-12.61M
QoQ: -132.85% | YoY: -938.92%
EPS
Decreasing
-0.06
QoQ: -132.80% | YoY: -931.43%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2026 224.69 -0.07 +3.6% View
Q1 2026 209.19 0.17 -11.7% View
Q3 2025 220.98 -0.05 -3.4% View
Q2 2025 231.26 -2.10 +0.7% View
Q1 2025 216.96 -0.06 -5.3% View